The main aim of the Divis R&D Centers is to design, develop and optimize commercially viable synthetic processes for APIs and Intermediates of Generics and customer’s discovery products.

Divis has four Research & Development facilities. The main R&D Center is at Hyderabad, working round the clock which was originally started as Divis Research Center (DRC) in Hyderabad and has a team of high caliber scientists.

Autoclaves and hydrogenators are available for conducting high temperature and high-pressure experimental reactions. The Centers have state-of-the-art instruments, an analytical laboratory and a library with 24 hours internet access. Divis R&D has evaluated more than 500 product opportunities and developed processes for more than 200 products, out of which 80 are already at commercial scale.

Apart from the above, each plant has its own R&D center.

Besides the required infrastructure, the Hyderabad plant’s R&D center has a Pilot Plant for scale-up studies, various materials of construction comprising 44 reactors of from 100 to 2000 Lt. capacity various materials of construction. All Four Research facilities are inspected and certified as per ISO – 9000 standards.

The third well equipped research facility of Divis at Visakhapatnam is primarily engaged in on process and commercial scale viability studies.

There is a pool of 200 scientists working in all the four research centers. Both DRC-Hyderabad and DRC-Vizag have been recognized by the Department of Science & Technology of Govt. of India, as industry research centers. The DRC-HYD centre is also recognized by a few universities for doctoral work.

Broad areas of engagement of the Research Centers:

R&D Units also carry out Process Justification, Cleaning Procedures, Specification Development, Analytical Method Development, Rework Procedures, Validation Studies, Stability Studies and Investigations.

Focus areas of engagement of each Research Center:

DRC - Hyderabad
Contract Research and investigations/studies in new areas of chemistry like peptides, nucleotides, carbohydrates and Projects of some leading multi-national pharmaceutical companies.

DRC - Vizag
Development of patent non- infringing processes for APIs going off-patent in the near future.

R&D - Unit-1 AND Unit-2

Evaluation of technologies from customer or the company’s research centers, completion of process justification, process optimization, scale-up, pilot studies and validation. R&D also gives process support and implements process improvements in the Plants. A few of the process improvements developed at Divis have also been implemented on client’s sites after maturation.